1. Prevalence of Delirium in Advance Cancer Patients Admitted in Hospice Centre and Outcome after Palliative Intervention.
- Author
-
Chishi, Kikato V., Patel, Bhavna Chirag, Umrania, Ravi A., Sanghavi, Priti Rashmin, Yadav, Varun Shaileshbhai, and Raval, Lekha V.
- Subjects
DIAGNOSIS of delirium ,CANCER patient psychology ,HOSPICE care ,RESEARCH ,NARCOTICS ,LENGTH of stay in hospitals ,INTENSIVE care units ,NONSTEROIDAL anti-inflammatory agents ,STEROIDS ,ANALGESICS ,TERTIARY care ,DISEASES ,COGNITION ,PROTON pump inhibitors ,ARTIFICIAL respiration ,DELIRIUM ,DISEASE prevalence ,QUESTIONNAIRES ,INSTITUTIONAL care ,CLASSIFICATION of mental disorders ,PALLIATIVE treatment ,LONGITUDINAL method ,ANTIBIOTICS ,PSYCHOLOGICAL distress - Abstract
Objectives: The assessment of prevalence of delirium in advanced cancer patients admitted in hospice centre and outcome after palliative intervention. The possible related risk factors for development of delirium. Material and Methods: This was prospective analytic study done at hospice centre attached with tertiary cancer hospital in Ahmedabad during August 2019 -- July 2021. This study was approved by the Institutional Review Committee. We selected patients according to following inclusion criteria (all patient admitted to hospice centre above 18 years, with advance cancer disease and on best supportive care) and exclusion criteria (Lack of informed consent, Inability to participate in study due to mentally retard or coma). The following information were collected: age, gender, address, type of cancer, comorbidities, history of substance abuse, history of (h/o) palliative chemotherapy or radiotherapy within last 3month, general condition, ESAS (Edmonton symptom assessment scale), ECOG (Eastern cooperative oncology group), PaP score (palliative prognostic score), medication including opioids, NSAIDs (Non-steroidal anti-inflammatory drugs), steroids, antibiotic, adjuvant analgesic, PPI (Proton pump inhibitor), anti-emetic etc. Delirium diagnosis was based on diagnostic criterion of DSM-IV text revised and MDAS. Results: In our study we found prevalence of delirium was 31.29% in advanced cancer patients admitted to hospice centre. We found most common type of delirium is hypoactive (34.7%) and mixed subtype (34.7%) followed by hyperactive (30.4%) delirium. Resolution of delirium was higher among hyperactive delirium (78.57%) followed by mixed subtype (50%) and hypoactive (12.5%). Mortality was higher among patient with hypoactive subtype (81.25%) followed by mixed (43.75%) and hyperactive delirium (14.28%). Conclusion: An identification and assessment of delirium is vital for acceptable end of life care within the palliative care in light of the fact that the presence of delirium is related with morbidity, mortality, prolonged ICU hospitalization, expanded time on a ventilator, and by and large more prominent medical services costs. Clinicians should utilize one of a few approved delirium assessment tools to help evaluate and archive cognitive function. Prevention and recognizing the clinical reason for delirium are generally the best method for diminishing the morbidity from delirium. The study results demonstrate that multi component delirium management or projects are generally proficient to lessen the prevalence and negative outcomes of delirium. It was found that palliative care intervention has quite a positive outcome as it not only focus on the mental health of the patients but also of family members who go through the same amount of distress and also help them to communicate properly and manage to settle the mental state and end the life without pain and distress. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF